Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-055974

Chief Financial Officer sold 23,400 shares at an average $61.41 ($1,437,010)

  • Chief Financial Officer acquired 23,400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2025-05-30 Option exercise 10b5-1 +23,400 $6.88 $160,992 133,329 D
Smith Hunter C Chief Financial Officer 2025-05-30 Sale 10b5-1 −4,407 $60.93 $268,515 128,922 D
Smith Hunter C Chief Financial Officer 2025-05-30 Sale 10b5-1 −18,993 $61.52 $1,168,495 109,929 D
Derivatives
Smith Hunter C Chief Financial Officer 2025-05-30 Option exercise · Stock Options (Right to Buy) 10b5-1 −23,400 77,194 D
Open-market sales · 23,400 sh · avg $61.41 · $1,437,010
Loading xslF345X05/tm2516959-1_4seq1.xml…